Published in Appl Environ Microbiol on November 01, 1985
Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci U S A (2009) 3.35
Legionnaires disease: historical perspective. Clin Microbiol Rev (1988) 2.88
Biodiversity of amoebae and amoeba-resisting bacteria in a hospital water network. Appl Environ Microbiol (2006) 1.80
Monitoring airborne fungal spores in an experimental indoor environment to evaluate sampling methods and the effects of human activity on air sampling. Appl Environ Microbiol (1993) 1.68
Legionella contamination of dental-unit waters. Appl Environ Microbiol (1995) 1.54
Legionella, protozoa, and biofilms: interactions within complex microbial systems. Microb Ecol (2009) 1.18
Environmental mimics and the Lvh type IVA secretion system contribute to virulence-related phenotypes of Legionella pneumophila. Infect Immun (2006) 1.15
Epidemiology and Ecology of Opportunistic Premise Plumbing Pathogens: Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa. Environ Health Perspect (2015) 1.14
Protocol for sampling environmental sites for legionellae. Appl Environ Microbiol (1987) 1.13
Characterization and deposition of respirable large- and small-particle bioaerosols. Appl Environ Microbiol (2008) 1.13
Meteorological factors and risk of community-acquired Legionnaires' disease in Switzerland: an epidemiological study. BMJ Open (2013) 1.07
Isolation of an amoeba naturally harboring a distinctive Legionella species. Appl Environ Microbiol (1998) 1.03
Molecular characterization of Legionella populations present within slow sand filters used for fungal plant pathogen suppression in horticultural crops. Appl Environ Microbiol (2003) 1.02
Potentially pathogenic bacteria in shower water and air of a stem cell transplant unit. Appl Environ Microbiol (2009) 0.89
Coaggregation occurs amongst bacteria within and between biofilms in domestic showerheads. Biofouling (2013) 0.88
Waterborne Nosocomial Infections. Curr Infect Dis Rep (2000) 0.87
Sources of airborne microorganisms in the built environment. Microbiome (2015) 0.87
Survey of legionella species found in thai soil. Int J Microbiol (2012) 0.85
Uncertainties associated with assessing the public health risk from Legionella. Front Microbiol (2014) 0.84
Novel light-activated antimicrobial coatings are effective against surface-deposited Staphylococcus aureus. Curr Microbiol (2008) 0.80
Convective Mixing in Distal Pipes Exacerbates Legionella pneumophila Growth in Hot Water Plumbing. Pathogens (2016) 0.79
Intra-amoeba multiplication induces chemotaxis and biofilm colonization and formation for Legionella. PLoS One (2013) 0.78
Spatial arrangement of legionella colonies in intact biofilms from a model cooling water system. Microbiol Insights (2013) 0.76
Negative pressure of the environmental air in the cleaning area of the materials and sterilization center: a systematic review. Rev Lat Am Enfermagem (2016) 0.75
New sampler for the collection, sizing, and enumeration of viable airborne particles. J Bacteriol (1958) 18.57
Detection of Legionnaires disease bacteria by direct immunofluorescent staining. J Clin Microbiol (1978) 17.69
Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens. J Clin Microbiol (1981) 11.09
Isolation of Legionella spp. from environmental water samples by low-pH treatment and use of a selective medium. J Clin Microbiol (1981) 6.88
An outbreak of Legionnaires' disease associated with a contaminated air-conditioning cooling tower. N Engl J Med (1980) 6.64
Legionnaires' disease in a transplant unit: isolation of the causative agent from shower baths. Lancet (1980) 4.04
Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires' disease. N Engl J Med (1982) 3.25
Isolation of Legionella pneumophila from hospital shower heads. Ann Intern Med (1981) 2.89
Subtypes of Legionella pneumophila serogroup 1 associated with different attack rates. Lancet (1983) 2.87
Legionella infections: a review of five years of research. Rev Infect Dis (1983) 2.30
Dose-response of guinea pigs experimentally infected with aerosols of Legionella pneumophila. J Infect Dis (1980) 2.07
Production of monoclonal antibodies to Legionella pneumophila serogroups 1 and 6. J Clin Microbiol (1983) 2.07
Legionnaires' disease associated with a hospital water system: a cluster of 24 nosocomial cases. Ann Intern Med (1983) 2.00
An outbreak in 1965 of severe respiratory illness caused by the Legionnaires' disease bacterium. J Infect Dis (1978) 1.84
Nosocomial Legionnaires' disease caused by aerosolized tap water from respiratory devices. J Infect Dis (1982) 1.81
Potable water as a source of Legionnaires' disease. JAMA (1985) 1.56
Survival of Legionella pneumophila in aerosols: effect of relative humidity. J Infect Dis (1980) 1.14
Selective media in air sampling: a review. J Appl Bacteriol (1971) 1.04
Legionella pneumophila contamination of a hospital humidifier. Demonstration of aerosol transmission and subsequent subclinical infection in exposed guinea pigs. Am Rev Respir Dis (1983) 0.94
Legionella pneumonia in guinea pigs exposed to aerosols of concentrated potable water from a hospital with nosocomial Legionnaires' disease. J Infect Dis (1983) 0.93
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 9.08
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med (1990) 5.55
Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med (1997) 4.84
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med (2001) 4.26
Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection. J Virol (1980) 3.16
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Subtypes of Legionella pneumophila serogroup 1 associated with different attack rates. Lancet (1983) 2.87
Location of the structural genes for glycoproteins gD and gE and for other polypeptides in the S component of herpes simplex virus type 1 DNA. J Virol (1982) 2.85
Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors. J Virol (1982) 2.68
Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein. J Virol (1982) 2.55
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis (1996) 2.55
Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. J Virol (1985) 2.42
Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest (1985) 2.28
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection. N Engl J Med (2001) 2.08
Production of monoclonal antibodies to Legionella pneumophila serogroups 1 and 6. J Clin Microbiol (1983) 2.07
Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol (1999) 1.91
Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS (1993) 1.87
Plasmid profiles of clinical and environmental isolates of Legionella pneumophila serogroup 1. J Clin Microbiol (1983) 1.79
Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA (1997) 1.74
Use of monoclonal antibodies against two 75,000-molecular-weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping. J Virol (1983) 1.73
Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333. J Infect Dis (2000) 1.60
Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med (1980) 1.54
Neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1992) 1.52
Difference in virulence of environmental isolates of Legionella pneumophila. J Clin Microbiol (1985) 1.46
Use of zidovudine following occupational exposure to human immunodeficiency virus. Clin Infect Dis (1992) 1.42
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). Antimicrob Agents Chemother (2000) 1.42
Relationship between colonization of hospital building with Legionella pneumophila and hot water temperatures. Appl Environ Microbiol (1983) 1.40
Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease Group. Arch Intern Med (1996) 1.39
Subtyping of Legionella pneumophila serogroup 1 isolates by monoclonal antibody and plasmid techniques. J Clin Microbiol (1987) 1.32
Comparison of Binax Legionella Urinary Antigen EIA kit with Binax RIA Urinary Antigen kit for detection of Legionella pneumophila serogroup 1 antigen. J Clin Microbiol (1996) 1.32
Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch Intern Med (1977) 1.31
Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. Clin Infect Dis (1999) 1.16
Prevalence and significance of Legionella pneumophila contamination of residential hot-tap water systems. J Infect Dis (1985) 1.14
The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am (1998) 1.14
Treatment of Clostridium difficile colitis and diarrhea with vancomycin. Am J Med (1981) 1.14
Danger of sputum purulence screens in culture of Legionella species. J Clin Microbiol (1994) 1.13
Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults. AIDS (2001) 1.08
Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother (1990) 1.07
Psychopathology in human immunodeficiency virus infection: lifetime and current assessment. Compr Psychiatry (1993) 1.06
Cell-mediated immunity in diabetes mellitus. Infect Immun (1978) 1.06
Lymphocyte transformation to Legionella pneumophila. J Clin Lab Immunol (1981) 1.05
Potential importance of Legionella species as etiologies in community acquired pneumonia (CAP). Diagn Microbiol Infect Dis (2000) 1.04
Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899. Antimicrob Agents Chemother (1982) 1.03
Serum bactericidal activity against Legionella pneumophila. J Clin Microbiol (1985) 0.97
Cerebrospinal fluid lymphocyte transformations in meningitis. Arch Intern Med (1979) 0.95
Foscarnet for suppression of human immunodeficiency virus replication. Antimicrob Agents Chemother (1994) 0.93
Stability of Legionella urinary antigens over time. Diagn Microbiol Infect Dis (1997) 0.92
Depression and neuropsychological performance in asymptomatic HIV infection. Am J Psychiatry (1993) 0.91
The effect of rings on microbial load of health care workers' hands. Am J Infect Control (1997) 0.90
Gastric sarcoidosis, presenting as antral scarring. Gastrointest Endosc (1976) 0.88
Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia. Clin Infect Dis (1999) 0.87
An emergency department-based pneumococcal vaccination program could save money and lives. Ann Emerg Med (1999) 0.86
Serological differences in Legionella pneumophila infections. J Clin Microbiol (1984) 0.86
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.85
Utilizing quality assurance as a tool for reducing the risk of nosocomial ventilator-associated pneumonia. Am J Med Qual (1996) 0.84
Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. J Clin Exp Neuropsychol (1994) 0.83
Serious infections in adults exposed to children with Haemophilus influenzae type b meningitis. Ann Intern Med (1981) 0.83
Sulfamethoxazole-trimethoprim treatment of guinea pigs infected with Legionella pneumophila. J Infect Dis (1984) 0.82
Cell-mediated immune responses in sporotrichosis. J Infect Dis (1979) 0.82
Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1993) 0.81
Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up. AIDS (1993) 0.80
Duration of illness and neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1994) 0.80
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044. Clin Infect Dis (1994) 0.80
Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections. CBPIS Study Group. Community-based Pneumonia Incidence Study. Radiology (1994) 0.79
Abrasive shirts may contribute to herpes gladiatorum among wrestlers. N Engl J Med (1989) 0.79
Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis. J Clin Immunol (1992) 0.79
Abnormal lymphocyte responses in residents of a town with a cluster of Hodgkin's disease. Clin Exp Immunol (1979) 0.78
Haemophilus influenzae cellulitis in an adult. Arch Intern Med (1979) 0.78
Role of macrophage D-region antigens and T-lymphocyte differentiation antigens in induction of gamma interferon. J Interferon Res (1985) 0.77
Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections. Am J Med (1989) 0.77
Oral ingestion of Legionella pneumophila. J Clin Lab Immunol (1986) 0.77
Zidovudine: counseling strategies and compliance. Am Pharm (1991) 0.77
Comparison of the effectiveness of moxalactam and cefazolin in the prevention of infection in patients undergoing abdominal operations. Diagn Microbiol Infect Dis (1985) 0.77
Therapy of skin, soft tissue, and bone infections with cefoxitin sodium. Rev Infect Dis (1989) 0.76
Diabetes mellitus presenting with ketoacidosis following pentamidine therapy in patients with acquired immunodeficiency syndrome. J Infect (1991) 0.76
Susceptibility of ninety-eight clinical isolates of Legionella to macrolides and quinolones using the Etest. Diagn Microbiol Infect Dis (1997) 0.76
Rate of CD4 decline and neuropsychological performance in HIV infection. Arch Neurol (1991) 0.76
Cord blood lymphocyte transformation responses to Legionella pneumophila. J Clin Lab Immunol (1982) 0.76
Effects of legal abortion on gynaecology. Br Med J (1972) 0.75
Community-acquired pneumonia. What's needed for accurate diagnosis. Postgrad Med (1996) 0.75
Pneumococcal vaccine: a different perspective. Arch Intern Med (1994) 0.75
Locally invasive oral candidiasis mimicking zygomycosis in a patient with diabetic ketoacidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 0.75
Intratracheal infection with L. pneumophila subtypes. J Clin Lab Immunol (1986) 0.75